Portage Biotech Inc reports results for the quarter ended in September - Earnings Summary

Follow us on Google News:
 Portage Biotech Inc reports results for the quarter ended in September - Earnings Summary
Image source: ©2022 Kalkine Media®

* Portage Biotech Inc reported a quarterly adjusted loss of 6 cents​​ per share for the quarter ended in September. The mean expectation of three analysts for the quarter was for a loss of 29 cents per share. * Reported revenue was zero​; analysts expected zero. * Portage Biotech Inc's reported EPS for the quarter was a loss of 6 cents​. * The mean earnings estimate of analysts had risen by about 2.2% in the last three months.​ * In the last 30 days there have been no earnings estimate revisions by analysts covering the company. * Portage Biotech Inc shares had fallen by 13.5% this quarter and lost 45.0% so far this year. * The company reported a quarterly loss of $949 thousand. * Wall Street's median 12-month price target for Portage Biotech Inc is $26.00 * The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." This summary was machine generated from Refinitiv data November 29 at 10:04 p.m. ​All figures in US dollars unless otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET, MISSED Sep. 30 2022 -0.29 -0.06 Beat Jun. 30 2022 -0.30 -0.13 Beat Mar. 31 2022 -0.28 -0.56 Missed Dec. 31 2021 -0.27 -0.26 Beat


The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK